The University of Medicine and Pharmacy in Craiova is seeking to procure laboratory reagents necessary for the implementation of the research project PNRR-III-C9-2022-I8, titled 'Targeting macrophages/monocytes in the aged ischemic brain by pharmacological, genetic, and cell-based tools.' This proje
Contract awarded. Originally published 1 years ago.
No single supplier dominates the field.
In healthcare medical, UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA has awarded 6 contracts to 6 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the procurement of research reagents necessary for the implementation of the project PNRR-III-C9-2022-I8, titled 'Targeting macrophages/monocytes in the aged ischemic brain by pharmacological, genetic, and cell-based tools.' This project is funded under contract number 760058/
The University of Medicine and Pharmacy in Craiova is seeking to purchase contrast agents for use in MRI and CT imaging scans conducted in its Medical Imaging Laboratory. Interested suppliers have the right to request clarifications or additional information regarding the procurement documentation.
The University of Medicine and Pharmacy in Craiova is seeking to purchase agricultural food products necessary for the operation of its canteen. Interested suppliers have the right to request clarifications or additional information regarding the procurement documentation. Any request for clarificat
The University of Medicine and Pharmacy in Craiova is seeking to purchase laboratory reagents necessary for the implementation of the project PNRR-III-C9-2022-I8, titled 'Targeting macrophages/monocytes in the aged ischemic brain by pharmacological, genetic, and cell-based tools.' This project is fu
Funding up to £3 million for human experimental medicine studies investigating the biological and psychological causes of gambling disorder development and recovery.
Apply for up to £26.25 million in MRC funding over 14 years to establish a centre of research excellence addressing complex health challenges.
Grants up to £200,000 available for early-stage, high-risk environmental research projects without requiring preliminary data, running for up to two years.
UKRI is funding empirical research to establish reliable estimates of the economic and social returns on R&D investments to guide public and private sector decision-making.
